首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   700篇
  免费   56篇
  国内免费   2篇
耳鼻咽喉   4篇
儿科学   20篇
妇产科学   16篇
基础医学   126篇
口腔科学   4篇
临床医学   72篇
内科学   173篇
皮肤病学   28篇
神经病学   31篇
特种医学   21篇
外科学   90篇
综合类   14篇
预防医学   62篇
眼科学   7篇
药学   45篇
中国医学   1篇
肿瘤学   44篇
  2023年   11篇
  2022年   19篇
  2021年   40篇
  2020年   19篇
  2019年   24篇
  2018年   29篇
  2017年   25篇
  2016年   22篇
  2015年   19篇
  2014年   24篇
  2013年   27篇
  2012年   35篇
  2011年   39篇
  2010年   17篇
  2009年   10篇
  2008年   28篇
  2007年   27篇
  2006年   22篇
  2005年   35篇
  2004年   27篇
  2003年   27篇
  2002年   33篇
  2001年   32篇
  2000年   23篇
  1999年   20篇
  1998年   11篇
  1997年   6篇
  1995年   2篇
  1992年   6篇
  1991年   6篇
  1990年   13篇
  1989年   11篇
  1988年   7篇
  1987年   9篇
  1986年   5篇
  1985年   10篇
  1984年   6篇
  1983年   7篇
  1982年   5篇
  1978年   1篇
  1977年   1篇
  1976年   2篇
  1974年   1篇
  1972年   2篇
  1971年   1篇
  1970年   2篇
  1969年   1篇
  1967年   1篇
  1966年   1篇
  1965年   2篇
排序方式: 共有758条查询结果,搜索用时 13 毫秒
101.
102.
This work was carried out to explore the compounds of bismuth with carbon using density functional theory (DFT)-based computations. The structures of the compounds BiC, BiC2, BiC3, Bi2C3, BiC5, and Bi2C5 were predicted at a generalized gradient approximation (GGA-PBE) level of theory. The calculations were carried out on the structures in unit cell and supercell geometries in slab and bulk periodicities. The structural and electronic properties of the mentioned compounds were investigated in detail. The calculations of the structures revealed lattice constants of the compounds for cubic unit cell as 212.2 pm for BiC, 176.9 pm for BiC2, 240.5 pm for BiC3, 232.4 pm for Bi2C3, and 354.5 pm for Bi2C5. The compounds BiC, BiC2, BiC3, BiC5, and Bi2C5 were found to be metallic, whereas Bi2C3 exhibited semiconducting character with a band gap of 0.305 eV. This work provides an initial framework for preparing new 2D materials from BixCy.  相似文献   
103.
A general palladium-catalysed selective C–H halogenation reaction is reported, which was successfully achieved for a large variety of functionalized aromatic rings incorporating diverse N-directing groups. By using simple alkali halides of MX type as the nucleophilic reagent source (M = Li, Na, K, Cs and X = I, Br and Cl), and phenyliodanediacetate oxidant, clean C–H-iodination, bromination and chlorination reactions were performed. This general protocol of selective ortho-monohalogenation, which complements but contrasts with the classical methods using electrophilic reagents, is achievable in a short time (30 min) with microwave irradiation assistance. The reaction was extended to substrates bearing N-directing pyridine, pyrimidine, pyrazole, oxazoline, naphtho[1,2-d]thiazole, and azobenzene groups. Notably, the topical and selectivity-challenging s-tetrazine, as a nitrogen-rich heteroaromatic, was successfully halogenated by this protocol.

A general palladium-catalysed selective C–H halogenation reaction is reported, which was successfully achieved for a large variety of functionalized aromatic rings incorporating diverse N-directing groups.  相似文献   
104.
105.
106.
107.
Sixty pharmacists in Johannesburg were randomly selected and questioned on their suggested treatment of acute infantile diarrhoea as well as their knowledge of oral rehydration therapy (ORT); 53 (88%) responded. Of 51 pharmacists who had treated diarrhoea in children, 8 (16%) had never heard of ORT, while 20 (39%) treated this condition with antidiarrhoeal drugs. These findings are perturbing, because acute diarrhoeal disease is the biggest cause of mortality of children aged 1-4 years in South Africa and ORT is recognised as an effective means of prevention of death.  相似文献   
108.
Two autochthonous cases of kala-azar, the first such report of the disease from Central and Southern Africa, are described. Both patients presented with generalized macules, papules and nodules without ulceration and both also had tuberculosis. Amastigotes were cultured from blood and identified in skin, bone marrow, liver and spleen.  相似文献   
109.
Dapsone is commonly used for pneumocystis carinii pneumonia (PCP) prophylaxis in immunocompromised patients. It has been used as an alternative therapy in the hematopoietic stem cell transplant (HSCT) setting in patients who can't tolerate trimethoprim-sulfamethoxazole. The Sulfone syndrome is not a well-known sequela of dapsone therapy and occurs at various doses, ranging from 50-300 mg/d. In all cases the syndrome occurs within 2 months of initiating therapy. Its clinical manifestations include: fever, methemoglobinemia, hemolytic anemia, exfoliative dermatitis and transaminits. A 51-year old female underwent a matched unrelated hematopoiectic stem cell transplant for acute mylogenous leukemia. Dapsone therapy was initiated on day +28 at a dose of 100 mg/day for PCP prophylaxis secondary to the patient's history of a sulfonamide allergy. On day +59, one month after initiation of therapy she developed hepatitis, hemolytic anemia, fever and methemoglobinemia of 8%. She was transferred to the intensive care unit and subsequently developed an exfoliative dermatitis. We conclude that the clinical presentation of this patient after HSCT on dapsone therapy coincide with the sulfone syndrome not previously described in a patients after HSCT.  相似文献   
110.
Penicillinase-producing strains of Neisseria gonorrhoeae (PPNG) were detected in nine out of 27 (3.2%) treatment failures in 310 cases of acute gonococcal urethritis in men in Lusaka, Zambia. Minimum inhibitory concentrations of penicillin for 17.2% of 233 gonococcal isolates were less than or equal to 0.05 microgram/ml, for 38.2% between 0.125 and 0.25 microgram/ml, and for 46.6% greater than or equal to 0.5 microgram/ml. At present the prevalence of PPNG in African countries is not known but is likely to increase rapidly unless simplified control schemes are adopted within the existing health care programmes. Endemic pockets of PPNG in a few countries can threaten worldwide efforts to control gonorrhoea.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号